Halozyme Therapeutics | 営業経費



Operating Expenses 変化する 日付
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Agios Pharmaceuticals USD 135.77M 1.11B 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amarin USD 67.47M 549K 2024-09
Amgen USD 6.78B 401M 2024-12
Baxter International USD 3.19B 644M 2024-12
Cytokinetics USD 155.97M 14.7M 2024-12
DBV Technologies USD 31.4M 3.6M 2024-09
Eli Lilly USD 7.32B 1.06B 2025-03
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Indivior 200M 193M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
MannKind USD 63.68M 11.62M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
United Therapeutics USD 411.6M 33.4M 2025-03



Halozyme Therapeutics 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - May 2025.